Multi-Modal Precision Medicine

• Rainbow Genomics, established in 2016, uses whole genome sequencing, proteomics, polygenic risk scores, pharmacogenomics & nutrigenomics, to help doctors and patients to understand genetic variations, leading to improved treatment and health care outcomes.

We Provide Answers - Patients, Parents and families

Q1. I don’t know what causes my symptoms?

Get a diagnosis within two months

Q2. My child has unexplained disorders.

Determine the genetic cause and improve treatment outcome.

Q3. My doctor says I am at risk?

Understand your lifetime and imminent disease risks using genetics

Q4. Worry?

Learn how to monitor and prevent debilitating diseases with findings from your DNA

How? We Provide clinical-grade Assessment

1. Genomics

   • Obtain a diagnosis in 2 months

2. Polygenic Risk Scores

   • Know your breast, prostate and colon cancer, heart attack, stroke and diabetes lifetime risks

3. Proteomics

   • How likely will I have a heart attack, stroke, get lung or prostate cancer, or develop high-risk prediabetes within a few years

4. Pharmacogenomics

   • Which drugs and at what dosages provide the least side effect for my treatment (180 medications)

5. Nutrigenomics

   • Am I deficient in absorbing brain health, heart health, and cancer prevention nutrients because of my genetics

6. Health Traits

   • What diet, exercise and food choices can help me lose weight effectively

Mission

• Rainbow Genomics helps doctors to understand genetic variations, leading to improved treatment and health care outcomes.

• We are a pioneer in the commercialization of genomic- and protein-based, diagnostic and preventive health care solutions to individuals.  

• We are committed to providing clinically-validated and evidence-based, multi-modal testing to Asian, Caucasian and mixed-race patients.  

Learn more about our Chief Medical Officer and his efforts on treating

• Hard-to-Diagnose Illnesses

• Unexplained Medical Problems

Markets

• We cover a range of health issues, including hereditary disorders in both children and adults, genetic testing for medication responses, and assessing common disease risks.

• We co-developed clinical applications with our institutional partners, and deploy credible clinical assessment products through highly-effective channels, to address both the domestic and medical tourism markets in Hong Kong, Japan, and the U.S.

Rainbow CEO on Expanding Precision Medicine Across Asia:

All Your DNA & 7000 Proteins

Clinically-Actionable Reports

Genomics

The human genome consists of 3 billion nucleotides or “letters” of DNA.

• Our whole genome sequencing test analyzes all 3 billion DNA letters, providing high-quality results, often matching or exceeding those from top U.S. and European medical institutions.

• We report common disease risks and health traits to help our patients prevent serious conditions and live healthier lives.

• If a patient is at high risk for a common disease, our 7000-blood-protein test can predict if this disease might happen soon.

• Doctors use this detailed information to better treat or prevent disease progression.

Unlike many consumer genetic tests that provide hundreds of findings that lack clinical relevance, Rainbow's whole genome sequencing provides clinically-actionable results that doctors can use to manage, treat, or prevent disorders.

Comply with U.S. Clinical Regulatory & Patient Privacy Standards

ACMG Guidelines

We follow the latest guidelines from the American College of Medical Genetics and Genomics (ACMG) for interpreting genetic tests. Our clinical partners provide reports that are reviewed and signed by board-certified medical directors or genetic specialists.

CAP-Accredited & CLIA-Certified Laboratories

All Rainbow tests are performed at CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvement Amendments) certified laboratories.

HIPAA/Patient Privacy

Patient data privacy – Rainbow follows the U.S. Health Insurance Portability and Accountability Act (HIPAA) privacy rules, established to protect the confidentiality of patients' individually identifiable health information.

Rainbow Genomics maintains operations in the U.S. and Hong Kong.

• Our English-speaking, Hong Kong-based project managers work closely with ordering physicians to collect patient samples, manage testing process, and coordinate physician report delivery. 

• Our partner laboratories, U.S. and Japanese medical institutions support the entire clinical testing process.

• Our genetic counselors and physician specialists provide multilingual (English with Japanese, Mandarin or Cantonese) genetic counseling to our patients, and consultation to physicians in local communities.

Since 2016

We’ve proudly partnered with doctors to improve patient care, delivering better, smarter, and more personalized treatment, making a real difference in the lives of patients!

Ownership

• Rainbow Genomics is majority-owned by its management team and employees.  

• We maintain 100% freedom to develop high-quality and credible genetic tests for patients .  We are committed to supporting physicians in local communities.